Stryker Granted FDA Clearance for Incompass Total Ankle
Incompass incorporates Adaptis Boney Ingrowth Technology and redesigned instrumentation to support long-term fixation, surgical flexibility and streamlined workflow....
Jun 25, 2025,
Stryker Granted FDA Clearance for Incompass Total Ankle
Smith+Nephew Launches TRIGEN MAX Tibia Nailing System
TRIGEN MAX offers trauma surgeons the choice of side-specific (right and left) nails for anatomic screw trajectories....
Jun 24, 2025,
ReGelTec Commences Clinical Trial for HYDRAFIL to Treat Low Back Pain
The first patient is treated in the investigational device exemption clinical trial of HYDRAFIL for disc augmentation....
Jun 24, 2025,
Carisma Therapeutics and OrthoCellix Partner on Cell Therapies for Orthopedic Disease
OrthoCellix is developing NeoCart as an autologous cartilage implant using patient cells to repair knee articular cartilage defects....
Jun 24, 2025,
Cerapedics Gains FDA Approval of PearlMatrix P-15 Bone Graft
PearlMatrix Bone Graft is the first and only bone growth accelerator proven to accelerate lumbar fusion....
Jun 23, 2025,
First Patient Treated with Alteon Short Tapered Wedge Hip
Exactech’s Alteon Stem is a next-generation solution designed to fit a broader range of femoral anatomies while conserving distal bone....
Jun 23, 2025,
Orthopedic Leaders Discuss the Future of Manufacturing
Excerpts from OMTEC 2025's keynote panel discussing issues and opportunities impacting orthopedic manufacturing....
Jun 23, 2025,
OMTEC Award Recipients Share Winning Perspectives
OMTEC 2025 award winners spoke about catalysts and obstacles to innovation in today’s orthopedic market....
Jun 23, 2025,
J&J Medtech Launches VOLT Wrist and Proximal Humerus Plating
These additions to the VOLT portfolio are anatomically designed for two of the most commonly fractured bones....
Jun 19, 2025,
First US Cases with PEEK-OPTIMA Freedom Total Knee
A U.S. IDE study is comparing the Freedom Knee with a PEEK-OPTIMA femoral component to a controlled registry of the...
Jun 19, 2025,
Loading new posts...
No more posts
